Skip to content
Open access

Exploring the anti-Helicobacter pylori activity of Guluchyadi Kashayam through in-vitro and in-silico analysis

Aug 2026 · In Silico Pharmacology · Vol 14 · 0 citations · 38 references
Medicine

TL;DR

The β-clamp protein is identified as a therapeutic target and CID 546,407 as a promising lead for drug development, driven by robust Van der Waals forces, which avoids the massive entropic penalties hindering other compounds.

Read PDF

Similar papers

Open access Aug 2026

Luteolin as a urease inhibitor: A novel therapeutic strategy against Helicobacter pylori

As a urease inhibitor, luteolin suppresses H. pylori by blocking ammonia production, thereby disrupting acid neutralization and inducing metabolic dysfunction, which collectively alleviates gastric damage and inflammation while minimizing microbiota disruption and resistance risk.

Xing-Ye Wang, Dongyue Zhou, Mingran Li et al. · 0 citations
Jul 2026

Discovery of novel cinnamic acid derivatives with anti-Helicobacter pylori mechanism.

Results suggested that compound 23 was a viable lead candidate for the treatment of Hp infection, and could cause severe cellular damage, disrupt biofilms, and inhibit urease, thereby blocking ammonia cloud formation.

Yong-Lian Li, Xiu-Ya Ye, Yuan-e Yang et al. · 0 citations
Jul 2026

Mechanisms of Hericium erinaceus polysaccharides on chronic atrophic gastritis: An integrated study of network pharmacology, molecular docking, in vivo experiments, and scRNA-seq.

It is demonstrated that HEP exerts gastroprotective effects against CAG through coordinated anti-inflammatory, antioxidant, and structure-dependent NF-κB inhibitory actions, supporting its potential as a promising natural agent for CAG intervention.

Ping Li, Jianran Hu, Yan-juan Yang et al. · 0 citations
Jul 2026

Elucidating the Activity of E-Lian Granule in Alleviating Chronic Atrophic Gastritis: Insights from Network Pharmacology, Molecular Docking, and Experimental Validation.

Findings indicate that ELKL exerts significant anti-inflammatory effects through the multi-component and multi-target regulation of inflammatory signaling pathways, thereby supporting its therapeutic potential in preventing the progression of CAG and IM.

Yini Tang, Yan Xue, Shigui Xue et al. · 0 citations
Open access Jul 2026

INVESTIGATION OF PHYTOCHEMICAL AND INVITRO ANTI ULCER ACTIVITY OF BOMBAX CEIBA AND COPTIS JAPONICA

Bombax ceiba exhibits excellent acid-neutralizing and cytoprotective effects attributed to phenolics and tannins, whereas Coptis japonica is a potent natural H⁺/K⁺-ATPase inhibitor due to its high alkaloid (berberine) content.

A. Aditi, Waseem Khan, Sanjay Singh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.